Skip to content
value.today

Surface Oncology

SURFUnlisted company
$59 Mlast known market cap, Jul 2023 — no current value
Compare
World rank
—
no current market cap
Revenue
$126 M
annual
value.today research
Net income
$59 M
47.0% margin
value.today research
Employees
—

Surface Oncology in brief

Surface Oncology is an unlisted company in the Biotechnology industry, based in the USA. It was founded in 2014. In its latest reported year it had sales of $126 M and a net profit of $59 M, about 47 cents of profit for every dollar of sales.

Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.

About Surface Oncology

Surface Oncology is a Clinical and Preclinical Pipeline of Immune Enhancing Antibody company candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies. The company annual revenue is 126.16 million USD and 76 employees as on 2020. The headquarters is in USA.

Surface Oncology timeline

1 events, 2014
  1. 2014
  2. 🏁
    · approximate
    Founded

Events of Surface Oncology from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Surface Oncology

Acquisitions and changes
No longer listed: ticker SURF is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$102 M$203 M$305 M$406 M2020202120222023

World rank over time

▼ down 2,632 places since 2020
2020-01-01: #21795#21,79520202021-01-01: #12616#12,61620212022-01-07: #18677#18,67720222022-12-25: #18677#18,67720222023-07-30: #24427#24,4272023

Rank in USA: #4,108 (Jan 2020) · #2,985 (Jan 2021) · #3,804 (Jan 2022) · #5,112 (Dec 2022) · #4,620 (Jul 2023)

Annual results

Revenue
$126 M
Operating income
—
Net income
$59 M

H-1B hiring at Surface Oncology#

1 labor condition applications certified in fiscal 2022 for 1 positions, at a median wage of $188 K a year.

Certified, FY2022
1
#2,053 among companies on value.today
Worker positions
1
Median wage offered
$188 K
a year, full-time
Applications filed
1
Surface Oncology: most frequent H-1B job titles in fiscal 2022
Job titlePositionsMedian wage offered
Director, GMP and QAValidation Engineers1$188 K

Where: Cambridge, MA 1

Surface Oncology: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202211$188 K1
FY202133$101 K3

How Surface Oncology compares in Biotechnology

  • Revenue$126 M · higher than 72% of 647
  • Net margin47.0% · higher than 97% of 408

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Surface Oncology🇺🇸$59 M—47.0%—
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

How current the figures are

Market cap:
Jul 30, 2023 (last known)
Profile updated:
Nov 14, 2026

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Surface Oncology? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Surface Oncology's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Surface Oncology? Suggest a correction